PTCL

Clinical trials for PTCL explained in plain language.

Never miss a new study

Get alerted when new PTCL trials appear

Sign up with your email to follow new studies for PTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New drug trial aims to keep aggressive lymphoma at bay

Disease control Not yet recruiting

This study is testing whether a drug called SHR2554 can help prevent cancer from coming back in people with peripheral T-cell lymphoma (PTCL) who have already responded to their first treatment. It will enroll about 30 adults who achieved a partial or complete response after init…

Matched conditions: PTCL

Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

PTCL

Get alerted when new PTCL trials appear

New drug trial aims to keep aggressive lymphoma at bay